Novel FUS mutations identified through molecular screening in a large cohort of familial and sporadic amyotrophic lateral sclerosis

C. Tarlarini, C. Lunetta, L. Mosca, F. Avemaria, N. Riva, V. Mantero, E. Maestri, A. Quattrini, M. Corbo, M. G. Melazzini, S. Penco

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background and purpose: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Approximately 5%-10% of cases are familial (FALS) and the remaining are sporadic (SALS). To date FUS mutations are responsible for 4%-6% of familial cases as well as 0.7%-1.8% of sporadic cases. Methods: The frequency of FUS mutations was investigated in an Italian cohort of 500 SALS and 40 FALS patients through direct sequencing of exons 5, 6, 13, 14 and 15. Results: Eight FUS mutation carriers were identified in five SALS (1%) and three FALS (7.5%), five already known and three new mutations: a de novo mutation was identified in a sporadic subject as well as the co-presence of FUS/C9ORF72 mutations in a FALS subject. The molecular and clinical details of the three patients harbouring a novel mutation (G245V, G509D and R491C) are presented here. Moreover the co-presence of the R491C mutation and C9ORF72 pathological expansion was found according to the oligogenic disease model. Conclusions: In conclusion our results revealed a higher frequency of FUS mutation carriers (7.5%) in FALS compared to literature data together with a higher presence of female gender.

Original languageEnglish
Pages (from-to)1474-1481
Number of pages8
JournalEuropean Journal of Neurology
Volume22
Issue number11
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

Mutation
Mutation Rate
Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis 1
Neurodegenerative Diseases
Exons

Keywords

  • Amyotrophic lateral sclerosis
  • Clinical features
  • FUS mutations
  • Genetics

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Novel FUS mutations identified through molecular screening in a large cohort of familial and sporadic amyotrophic lateral sclerosis. / Tarlarini, C.; Lunetta, C.; Mosca, L.; Avemaria, F.; Riva, N.; Mantero, V.; Maestri, E.; Quattrini, A.; Corbo, M.; Melazzini, M. G.; Penco, S.

In: European Journal of Neurology, Vol. 22, No. 11, 01.11.2015, p. 1474-1481.

Research output: Contribution to journalArticle

Tarlarini, C, Lunetta, C, Mosca, L, Avemaria, F, Riva, N, Mantero, V, Maestri, E, Quattrini, A, Corbo, M, Melazzini, MG & Penco, S 2015, 'Novel FUS mutations identified through molecular screening in a large cohort of familial and sporadic amyotrophic lateral sclerosis', European Journal of Neurology, vol. 22, no. 11, pp. 1474-1481. https://doi.org/10.1111/ene.12772
Tarlarini, C. ; Lunetta, C. ; Mosca, L. ; Avemaria, F. ; Riva, N. ; Mantero, V. ; Maestri, E. ; Quattrini, A. ; Corbo, M. ; Melazzini, M. G. ; Penco, S. / Novel FUS mutations identified through molecular screening in a large cohort of familial and sporadic amyotrophic lateral sclerosis. In: European Journal of Neurology. 2015 ; Vol. 22, No. 11. pp. 1474-1481.
@article{53ba9a48e9de4fbeb694a9ec858dab01,
title = "Novel FUS mutations identified through molecular screening in a large cohort of familial and sporadic amyotrophic lateral sclerosis",
abstract = "Background and purpose: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Approximately 5{\%}-10{\%} of cases are familial (FALS) and the remaining are sporadic (SALS). To date FUS mutations are responsible for 4{\%}-6{\%} of familial cases as well as 0.7{\%}-1.8{\%} of sporadic cases. Methods: The frequency of FUS mutations was investigated in an Italian cohort of 500 SALS and 40 FALS patients through direct sequencing of exons 5, 6, 13, 14 and 15. Results: Eight FUS mutation carriers were identified in five SALS (1{\%}) and three FALS (7.5{\%}), five already known and three new mutations: a de novo mutation was identified in a sporadic subject as well as the co-presence of FUS/C9ORF72 mutations in a FALS subject. The molecular and clinical details of the three patients harbouring a novel mutation (G245V, G509D and R491C) are presented here. Moreover the co-presence of the R491C mutation and C9ORF72 pathological expansion was found according to the oligogenic disease model. Conclusions: In conclusion our results revealed a higher frequency of FUS mutation carriers (7.5{\%}) in FALS compared to literature data together with a higher presence of female gender.",
keywords = "Amyotrophic lateral sclerosis, Clinical features, FUS mutations, Genetics",
author = "C. Tarlarini and C. Lunetta and L. Mosca and F. Avemaria and N. Riva and V. Mantero and E. Maestri and A. Quattrini and M. Corbo and Melazzini, {M. G.} and S. Penco",
year = "2015",
month = "11",
day = "1",
doi = "10.1111/ene.12772",
language = "English",
volume = "22",
pages = "1474--1481",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "11",

}

TY - JOUR

T1 - Novel FUS mutations identified through molecular screening in a large cohort of familial and sporadic amyotrophic lateral sclerosis

AU - Tarlarini, C.

AU - Lunetta, C.

AU - Mosca, L.

AU - Avemaria, F.

AU - Riva, N.

AU - Mantero, V.

AU - Maestri, E.

AU - Quattrini, A.

AU - Corbo, M.

AU - Melazzini, M. G.

AU - Penco, S.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Background and purpose: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Approximately 5%-10% of cases are familial (FALS) and the remaining are sporadic (SALS). To date FUS mutations are responsible for 4%-6% of familial cases as well as 0.7%-1.8% of sporadic cases. Methods: The frequency of FUS mutations was investigated in an Italian cohort of 500 SALS and 40 FALS patients through direct sequencing of exons 5, 6, 13, 14 and 15. Results: Eight FUS mutation carriers were identified in five SALS (1%) and three FALS (7.5%), five already known and three new mutations: a de novo mutation was identified in a sporadic subject as well as the co-presence of FUS/C9ORF72 mutations in a FALS subject. The molecular and clinical details of the three patients harbouring a novel mutation (G245V, G509D and R491C) are presented here. Moreover the co-presence of the R491C mutation and C9ORF72 pathological expansion was found according to the oligogenic disease model. Conclusions: In conclusion our results revealed a higher frequency of FUS mutation carriers (7.5%) in FALS compared to literature data together with a higher presence of female gender.

AB - Background and purpose: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Approximately 5%-10% of cases are familial (FALS) and the remaining are sporadic (SALS). To date FUS mutations are responsible for 4%-6% of familial cases as well as 0.7%-1.8% of sporadic cases. Methods: The frequency of FUS mutations was investigated in an Italian cohort of 500 SALS and 40 FALS patients through direct sequencing of exons 5, 6, 13, 14 and 15. Results: Eight FUS mutation carriers were identified in five SALS (1%) and three FALS (7.5%), five already known and three new mutations: a de novo mutation was identified in a sporadic subject as well as the co-presence of FUS/C9ORF72 mutations in a FALS subject. The molecular and clinical details of the three patients harbouring a novel mutation (G245V, G509D and R491C) are presented here. Moreover the co-presence of the R491C mutation and C9ORF72 pathological expansion was found according to the oligogenic disease model. Conclusions: In conclusion our results revealed a higher frequency of FUS mutation carriers (7.5%) in FALS compared to literature data together with a higher presence of female gender.

KW - Amyotrophic lateral sclerosis

KW - Clinical features

KW - FUS mutations

KW - Genetics

UR - http://www.scopus.com/inward/record.url?scp=84943223177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943223177&partnerID=8YFLogxK

U2 - 10.1111/ene.12772

DO - 10.1111/ene.12772

M3 - Article

C2 - 26176978

AN - SCOPUS:84943223177

VL - 22

SP - 1474

EP - 1481

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 11

ER -